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Skeletal muscle regeneration mainly depends on satellite cells, a population of resident
muscle stem cells. Despite extensive studies, knowledge of the molecular mechanisms
underlying the early events associated with satellite cell activation and myogenic
commitment in muscle regeneration remains still incomplete. Cripto is a novel regulator of
postnatal skeletal muscle regeneration and a promising target for future therapy. Indeed,
Cripto is expressed both in myogenic and inflammatory cells in skeletal muscle after
acute injury and it is required in the satellite cell compartment to achieve effective muscle
regeneration. A critical requirement to further explore the in vivo cellular contribution
of Cripto in regulating skeletal muscle regeneration is the possibility to overexpress
Cripto in its endogenous configuration and in a cell and time-specific manner. Here we
report the generation and the functional characterization of a novel mouse model for
conditional expression of Cripto, i.e., the Tg:DsRedloxP/loxPCripto-eGFP mice. Moreover,
by using a satellite cell specific Cre-driver line we investigated the biological effect of
Cripto overexpression in vivo, and provided evidence that overexpression of Cripto in the
adult satellite cell compartment promotes myogenic commitment and differentiation, and
enhances early regeneration in a mouse model of acute injury.
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Introduction
The responses of skeletal muscle tissue following acute or chronic damages are highly complex
and coordinated processes, involving many different cell populations that interact each other
to promote muscle regeneration, inflammation and angiogenesis, until full regeneration of the
tissue and its functional recovery. This process is tightly controlled by signals released by the
damaged fibers, which lead to the activation of the quiescent satellite cells, i.e., the myogenic
stem cell population that is among the major players responsible for the regeneration of
skeletal muscle (Collins et al., 2005). Following an injury, the satellite cells are activated and
proliferate as myogenic progenitors that migrate to the damaged site, differentiate and fuse
each other to form new myofibers (Hawke and Garry, 2001; Chargé and Rudnicki, 2004). This
sequential process is correlated with the finely regulated expression of the Myogenic Regulatory
Factors (MRFs). Indeed, quiescent satellite cells express Pax7 and, upon activation, upregulate
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the myogenic transcription factor MyoD. Upon commitment to
differentiation these transient amplifying cells (Pax7+/MyoD+)
downregulate Pax7 and upregulate differentiation genes, as
Myogenin and MRF4, while a subset of these cells downregulate
MyoD retaining Pax7 expression to replenish the pool of
quiescent satellite cells (Zammit et al., 2004; Olguin et al.,
2007; Tajbakhsh, 2009). Beside satellite cells, regeneration process
is also orchestrated by the crosstalk between heterogeneous
cell populations that are recruited/activated after damage,
such as the inflammatory cells that are always associated
with tissue regeneration, supporting myogenic progression by
interacting with satellite cells (Kharraz et al., 2013; Saclier et al.,
2013). Besides extensive studies, knowledge of the mechanisms
underlying this highly orchestrated process and how the different
cell populations establish their fate is still far to be fully
elucidated, and much less is known on the extrinsic regulation
of this process (Bentzinger et al., 2010). We have recently
demonstrated that Cripto, a key regulator of early vertebrate
embryogenesis (Shen and Schier, 2000; Minchiotti et al., 2001),
is a new player in this process (Guardiola et al., 2012). Cripto
is a GPI-anchored protein (Minchiotti et al., 2001) and a
developmental factor required for correct orientation of the
anterior–posterior axis in the vertebrate embryos (Chu et al.,
2005; Minchiotti, 2005). Despite its well-characterized role in
embryo development and embryonic stem cell differentiation
(Minchiotti, 2005), the role of Cripto in adult life has been
poorly investigated also due to the fact that Cripto knockout
mice are embryonic lethal (Ding et al., 1998; Xu et al., 1999),
and that its expression is almost absent in adult physiological
conditions. Indeed, Cripto expression is undetectable in skeletal
muscles under baseline conditions. However, it becomes rapidly
and transiently re-expressed after acute injury, both in myogenic
and inflammatory cells, and it is required in the myogenic
compartment to achieve an efficient regeneration (Guardiola
et al., 2012). Interestingly, a soluble form of the protein (sCripto)
is able to rescue the effect of genetic inactivation of Cripto,
thus recapitulating the function of endogenous membrane
form of the protein (Guardiola et al., 2012). Yet, the cellular
contribution of Cripto in skeletal muscle repair remains to be
further clarified, and its knowledge is limited also by the absence
of mouse models for conditional and tissue–specific Cripto
expression. Here we report the generation and characterization
of novel transgenic mice for conditional expression of Cripto
in its endogenous configuration, which allowed us to study the
biological effect of satellite cell-specific Cripto overexpression on
muscle regeneration and myogenic cell fate determination.
Results
Generation of Conditional Cripto Gain of
Function Transgenic Mice
To get insight into the cellular contribution of Cripto in
skeletal muscle regeneration, and to finely modulate Cripto
expression in vivo, we generated a novel transgenic mouse
line for conditional Cripto expression based on the Cre-
loxP strategy. To generate the pDsRedloxP/loxPCripto targeting
vector, a Cripto-IRES-eGFP cassette was inserted downstream
of the DsRed gene sequence followed by three termination
sequences, and flanked by two LoxP sites (see Materials
and Methods for details; Figure 1A). The effectiveness of the
pDsRedloxP/loxPCripto vector was first evaluated in vitro. To
this end, HEK-293T cells were transfected with the pCMV-Cre,
expressing the Cre recombinase, and the pDsRedloxP/loxPCripto
plasmids, either alone or in combination, and Cripto protein
expression was evaluated. We first verified that eGFP expression
was induced in cells cotransfected with pDsRedloxP/loxPCripto
and pCMV-Cre (Figure S1A). Accordingly, Cripto protein was
specifically induced (Figure 1B) and, as expected, it localized at
the cell membrane (Minchiotti et al., 2000) of eGFP expressing
cells (Figure S1B). Following the in vitro validation of the
targeting vector, transgenic mice were generated by pronuclear
injection, and the presence of the transgene in the offspring
was assessed by PCR genotyping of tail biopsies (Figures 1C,D).
One out of three transgenic mice obtained gave germline
transmission and carried two copies of the transgene that
segregated independently in the offspring (Figure 1E). Two
founder lines were thus established and bred to FVB/N wild
type mice to generate the Tg:DsRedloxP/loxPCripto-eGFP(A) and
Tg:DsRedloxP/loxPCripto-eGFP(B) colonies (from now onwards
named Tg:Cripto(A) and Tg:Cripto(B), respectively).
Functional Characterization of the Tg:Cripto
Transgenic Lines
Different studies have shown that significative differences
exist in the expression level of the same transgene between
individual founder siblings, due to different integration loci,
and the influence of the genomic sequences flanking the
integration site (Palmiter et al., 1982; Overbeek et al., 1986).
To characterize Tg:Cripto(A) and Tg:Cripto(B) transgenic lines,
we first assessed DsRed expression in freshly isolated muscles
by direct fluorescence and found a stronger DsRed signal in
Tg:Cripto(A) compared to Tg: Cripto(B) muscles (Figure 1F).
We thus evaluated whether Cripto was expressed upon Cre-
mediated recombination in vivo. To this end, TA muscles of
both transgenic lines were injected with Adeno Associated
Virus 9 (Inagaki et al., 2006) encoding Cre recombinase (AAV-
Cre) or empty vector (AAV-Cntl) as control. Ten days after
infection, TA muscles were explanted and genotyped by PCR.
As expected, a 838-bp band characterizing the recombining
allele was specifically detected in the AAV-Cre injected muscles
(Figure 1G), and Cripto protein was induced at different levels
as determined by ELISA-based assay (2.36 ± 0.06 ng/mg in
Tg:Cripto(A) vs. 0.43± 0.09 ng/mg in Tg:Cripto(B); ∗∗P = 0.005)
(Figure 1H).
All together these data demonstrate that Cripto expression is
regulated upon Cre-mediated recombination and is induced at
different levels in the two transgenic lines.
Time -Dependent Effect Of Cripto
Overexpression in Adult Satellite Cells on
Skeletal Muscle Regeneration
We have recently shown that adenovirus–mediated
soluble Cripto (sCripto) overexpression accelerates muscle
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FIGURE 1 | (A) Schematic representation of the pDsRedloxP/loxPCripto
targeting vector. The nuclear DsRed gene flanked by two loxP sites and
followed by three termination sequences (S) is transcribed by a constitutive
CMV-β-Actin (CMV-β-Ac) promoter. Upon cre- mediated recombination, the
DsRed sequence is excised and the Cripto-IRES-eGFP cassette is
transcribed from the CMV/β-actin promoter. (B) Western blot analysis using
anti-Cripto antibody on total protein extracts of HEK-293T cells transfected
with pDsRedloxP/loxPCripto vector either alone or in combination with
pCMV-Cre vector. Gapdh was used as a loading control. Protein extracts
from undifferentiated mouse embryonic stem cells (ESCs) were used as
positive control (C+). (C) Schematic representation of the genotyping
strategy. Location of PCR primers (black arrowheads) and the probe (black
bar) used for genotyping are indicated. Numbered boxes represent wild-type
exons (black). E, EcoRI. (D) Representative PCR screening on tail genomic
DNA from mice generated after oocyte injection. Primers a-a′ (top panel)
amplified a 247-bp fragment of the wild-type Cripto locus and a 156-bp
fragment of the Cripto transgene. Primers b-b’ (bottom panel) amplified a
2700-bp fragment spanning the DsRed-IRES-Cripto cassette. (E)
Genotyping by Southern blot analysis. Genomic DNA from wild type
(Continued)
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FIGURE 1 | Continued
(WT), founder (1) and F1 offspring mice (from 1.1 to 1.6) was digested
with EcoRI and hybridized with eGFP probe shown in (C). The sizes of
hybridized fragments are indicated in kilobases. (F) Representative
pictures of direct fluorescence of freshly isolated skeletal muscle from
Tg:Cripto(A) and Tg:Cripto(B) mice, showing different levels of DsRed
expression. (G) PCR screening of biopsy from Tg:Cripto(A) and
Tg:Cripto(B) TA muscles infected with either AAV-Cre or AAV-Control
(AAV-Cntl). Primers c-c’ (C) amplified a 1995-bp fragment of the
transgenic allele and a 838-bp fragment of the recombining allele. (H)
ELISA assay of Cripto protein levels expressed as ng/mg of tissue in
Tg:Cripto(A) and Tg:Cripto(B) muscles infected with AAV-Cre and
AAV-Cntl (2.36 ± 0.06 ng/mg in Tg:Cripto(A) vs. 0.43 ± 0.09 ng/mg in
Tg:Cripto(B); **P ≤ 0.005).
regeneration induced by acute injury (Guardiola et al.,
2012). Nevertheless, viral mediated Cripto expression does
not allow us to discriminate between the inflammatory
and satellite cell contribution of Cripto overexpression.
To overcome this limitation, we crossed Tg:Cripto(A)
and Tg:Cripto(B) mice with the tamoxifen-inducible
Tg:Pax7CreERT2 mice (Mourikis et al., 2012) and obtained
the Tg:Pax7CreERT2::DsRedloxP/loxPCripto-eGFP(A) and
Tg:Pax7CreERT2::DsRedloxP/loxPCripto-eGFP(B) trangenic
lines (from now onwards named Tg:Pax7CT2::Cripto(A) and
Tg:Pax7CT2::Cripto(B)) (Figure 2A). We first assessed the
effects of satellite cell-specific Cripto overexpression on skeletal
muscle regeneration. To this end, Tg:Pax7CT2::Cripto(A)
and Tg:Pax7CT2::Cripto(B) adult mice and their control
littermates were treated with tamoxifen once a day for 5 days;
at day 4, muscle regeneration was triggered in TA muscles
by local injection of cardiotoxin (CTX; Figure 2A). Genetic
recombination was first confirmed by PCR analysis on TA
muscle genomic DNA (Figure 2B, Figure S2A), and Cripto
protein levels were quantified by ELISA assay on total protein
extracts at different time points after injury. Increased Cripto
protein levels were detected in both Tg:Pax7CT2::Cripto(A)
and Tg:Pax7CT2::Cripto(B) mice compared to control, with
Tg:Pax7CT2::Cripto(A) showing the highest levels of Cripto upon
Cre-mediated recombination (Figure 2C, Figure S2B). To assess
if Cripto overexpression might influence muscle regeneration,
we first evaluated the expression of the embryonic Myosin
Heavy Chain (eMyHC), which is a marker of newly regenerated
fibers, at day 8 after injury. Both immunofluorescence and
Western blot analysis clearly showed increased eMyHC
protein levels in Tg:Pax7CT2::Cripto(A) mice compared to their
control littermates (Figures 2D,E). In line with these findings,
expression of both neonatal Myosin Heavy Chain (nMyHC)
and the early muscle differentiation marker Myogenin (Myog)
similarly increased in the overexpressing mice (Figures 2F,G).
Furthermore, expression of Myostatin (Mstn), which is a
negative regulator of muscle growth (Thomas et al., 2000), was
significantly reduced in Tg:Pax7CT2::Cripto(A)mice compared to
control (Figure 2H). Of note, similar results were obtained from
the analysis of the other transgenic line (Tg:Pax7CT2::Cripto(B);
Figures S2C–F). Morphological analysis of H&E-stained TA
muscle sections at day 8 showed that the number of myofibers
containing more than one nucleus (n >1) significantly increased
in Cripto overexpressing mice compared to control (0.12 ±
0.02 for Tg:Pax7CT2::Cripto(A) vs. 0.06 ± 0.01 for Tg:Cripto(A)
of fibers; ∗P ≤ 0.05; Figures 3A,B). Interestingly, while there
was no significant difference in Cross Sectional Area (CSA)
between the two groups at day 8 (Figures 3A,C), later on
(i.e., at day 15) both CSA distribution and the relative average
values significantly increased in the Tg:Pax7CT2::Cripto(A) mice
compared to control (Figures 3A,D,E). To assess if the positive
effect of Cripto overexpression on muscle regeneration was
either transient or persistent, we extended the analysis to a later
time point (i.e., at day 30). Morphometric analysis of the CSA
showed no difference in the distribution of muscle fibers in the
two groups at day 30 (Figures 3A,F); thus providing evidence
of a time-dependent effect of satellite cell -Cripto overexpression
on skeletal muscle regeneration. Most remarkably, similar
experiments carried on the Tg:Pax7CT2::Cripto(B) mice gave
comparable results (Figures S3A–F), thus ruling out the
possibility of a position-effect of the transgene.
Conditional Overexpression of Cripto in Satellite
Cells Enhances Myogenic Differentiation
To determine how Cripto overexpression in the satellite cells
impact on skeletal muscle regeneration, we first evaluated
its effect on early stages of myoblast differentiation in vitro.
To address this issue, we determined the fusion index (i.e.,
the percentage of the MF20+ cells with n ≥ 2 nuclei) of the
postnatal myogenic progenitor cells (MPCs) isolated from
hindlimb muscles of new-born Tg:Pax7CT2::Cripto(A) mice
and their Tg:Cripto(A) control littermates at postnatal (P) day
7. Cre-mediated recombination was induced by tamoxifen
injection (Figure 4A) and assessed by PCR genotyping of muscle
tissues (Figure 4B). We then verified that Cripto protein was
induced in Tg:Pax7CT2::Cripto(A) by ELISA assay on postnatal
MPCs (70.8 ± 14 ∗ 10−2 pg/µg for Tg:Pax7CT2::Cripto(A)
vs. 32.1 ± 2.6 ∗ 10−2 pg/µg for Tg:Cripto(A); ∗P ≤ 0.05;
Figure 4C). Cells were maintained in culture for 24 h in
proliferation medium and then shifted to differentiation medium
(DM) for 24 and 72 h (Figure 4D). Quantitative analysis
showed that the percentage of MF20+ cells with n ≥ 2 nuclei
progressively increased in cultures from Tg:Pax7CT2::Cripto(A)
mice compared to control, at both time points (29.03 ± 1.79%
for Tg:Pax7CT2::Cripto(A) vs. 18.4 ± 2.75% for Tg:Cripto(A) at
24 h; 35.85± 2.24% for Tg:Pax7CT2::Cripto(A) vs. 26.87± 1.08%
for Tg:Cripto(A) at 72 h; ∗P ≤ 0.05; Figure 4E), thus suggesting
that Cripto overexpression enhanced in vitro myoblasts to
myotubes differentiation. In line with these findings, the
percentage of Pax−/MyoD+ cells significantly increased in
Tg:Pax7CT2::Cripto(A) mice compared to control (9.92 ±
1.88% Pax−/MyoD+ for Tg:Pax7CT2::Cripto(A) vs. 3 ± 1.62%
Pax−/MyoD+ for Tg:Cripto(A); ∗P ≤ 0.05; Figures S4A,B).
Interestingly, these results are in line with data previously
reported on isolated myofibers in culture in which addition
of sCripto increases the number of Pax7−/MyoD+ myogenic
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FIGURE 2 | (A) Schematic representation of mouse breeding (upper panel)
and Cripto conditional gain of function strategy in adult satellite cells (lower
panel). Tamoxifen were injected i.p., in adult (5 weeks old)
Tg:Pax7CT2::Cripto mice and Tg:Cripto control littermates once a day for 5
days. At day 4, regeneration was triggered by CTX injection in TA muscle
of both groups, and analysis performed at the indicated time points (days
8, 15, and 30). The consecutive bars indicate the days. (B) PCR screening
on muscle genomic DNA showing tamoxifen-induced recombination only in
the muscle of Tg:Pax7CT2::Cripto(A). Primers c-c′ (See Figure 1C)
amplified a 1995-bp fragment of the transgenic allele and a 838-bp
fragment of the recombining allele. The recombining allele is detected in the
muscle (M; lanes 1, 2) but not in the liver (L; lane 3) of
Tg:Pax7CT2::Cripto(A) mice, and is not detected in the muscle (M; lanes 4,
5) and in the liver (L; lane 6) of Tg:Cripto(A) control littermates. (C) ELISA
assay of Cripto protein levels in TA muscles at different time points after
CTX injection expressed as pg/mg of muscle tissue at the indicated time
points. Values are mean ± SEM of n = 5 mice/group. *P ≤ 0.05;
***P = 0.0005. (D) Representative pictures of embryonic Myosin Heavy
Chain (eMyHC) Immunofluorescence on TA sections from
Tg:Pax7CT2::Cripto(A) mice and Tg:Cripto(A) control littermates at day 8.
Scale bars = 100µm. (E) Representative Western blot using anti-eMyHC
antibody on total protein extracts of TA muscles from Tg:Pax7CT2::Cripto(A)
mice and their Tg:Cripto(A) control littermates at day 8 after CTX. β-Actin
was used as a loading control. The densitometric analysis is expressed as
Arbitrary Densitometric Unit (ADU) expressing the eMyHC/β-Actin ratio.
Values are mean ± SEM of n = 3 mice/group. **P = 0.005. (F–H) qRT-PCR
analysis of neonatal Myosin Heavy Chain (nMyHC) (F) Myogenin (Myog) (G)
and Myostatin (Mstn) (H) on TA muscle total RNAs from
Tg:Pax7CT2::Cripto(A) mice and the Tg:Cripto(A) control littermates at day
8 after CTX injection. Values are mean ± SEM, 5 mice/group. *P ≤ 0.05.
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FIGURE 3 | (A) Representative H&E staining of TA muscle sections from
Tg:Pax7CT2::Cripto(A) and Tg:Cripto(A) TA muscles at the indicated time
points. Scale bars = 50µm. (B) Morphological analysis on muscle
sections at day 8 after injury showing the number of myofibers
containing more than one central nuclei/area in each group. Values are
mean ± SEM, 5 mice/group *P ≤ 0.05. (C) Average of centrally
nucleated myofibers size values in TA muscle sections at day 8 after
injury. Values are mean ± SEM, 5 mice/group. (D) Myofiber Cross
Sectional Area distribution at 15 days after CTX injection; 5 mice/group.
(E) Average of centrally nucleated myofibers size values in TA muscle
sections at day 15 after injury of Tg:Pax7CT2::Cripto(A) mice and
Tg:Cripto(A) control littermates. Values are mean ± SEM, 5 mice/group.
**P ≤ 0.005. (F) Myofiber Cross Sectional Area distribution at 30 days
after CTX injection; 4 mice/group.
cell population, promoting satellite cell progression into the
myogenic lineage (Guardiola et al., 2012). We thus went on
and extended the analysis in vivo to assess the effects of Cripto
overexpression on the distribution of the satellite cell population
during muscle regeneration. To this end, TA muscle sections
of Tg:Pax7CT2::Cripto(A) mice and their control littermates
at day 8 after injury (see Figure 2A) were double stained
with anti-Pax7 and anti-MyoD antibodies (Figure 4F) and
the frequency of (i) quiescent satellite cells (Pax7+/MyoD−),
(ii) transient amplifying cells (Pax7+/MyoD+), and (iii) cells
committed to myogenic differentiation (Pax7−/MyoD+)
was evaluated. Remarkably, the frequency of Pax7−/MyoD+
cells significantly increased in Tg:Pax7CT2::Cripto(A) mice
compared to control (0.32 ± 0.03 for Tg:Pax7CT2::Cripto(A)
vs. 0.16 ± 0.04 for control of Pax7−/MyoD+ cells; ∗P ≤ 0.05;
Figures 4F,G), at the expense of Pax7+/MyoD+, which
conversely decreased in Tg:Pax7CT2::Cripto(A) mice (0.13 ±
0.04 for Tg:Pax7CT2::Cripto(A) vs. 0.3 ± 0.05 for control
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FIGURE 4 | (A) Schematic representation of experimental strategy for
myogenic progenitor cells (MPCs) isolation. Tamoxifen was injected once a
day for 5 days (from P1 to P5) in new-born Tg:Pax7CT2::Cripto(A) mice and
their control littermates, and MPCs were isolated at P7. (B) PCR analysis on
muscle genomic DNA showing tamoxifen-induced recombination in
Tg:Pax7CT2::Cripto(A) mice. Primers c-c′ (Figure 1C) amplified a 1995-bp
fragment of the transgenic allele and a 838-bp fragment of the recombining
allele. (C) ELISA assay of Cripto protein levels in primary myoblasts from
Tg:Pax7CT2::Cripto(A) and control mice expressed as pg/µg of total protein
extracts. Values are mean ± SEM of n = 3. *P ≤ 0.05. (D) Representative
pictures of Tg:Pax7CT2::Cripto(A) and Tg:Cripto(A) myotubes after 24 and
72 h in differentiation medium (DM) and stained with MF20 antibody. Scale
bars = 100µm. (E) Fusion index was calculated as the percentage of MF20+
cells with n = 2 nuclei at 24 and 72 h in DM. The analysis was performed on
20 independent and random chosen microscope fields. Values are mean ±
SEM of 3 independent experiments. *P = 0.05. (F) Representative pictures of
double immunofluorescence with antibodies anti-Pax7 (green) and anti-MyoD
(red) in TA muscles at day 8 after injury. Nuclei were counterstained with
DAPI. Arrowheads indicate Pax7+/MyoD− (green), Pax7+/MyoD+ (yellow)
and Pax7−/MyoD+ (white) cells. Scale bars = 100µm. (G) Effect of satellite
cells-Cripto overexpression on Pax7±/MyoD± cell distribution in vivo. The
number Pax7±/MyoD±/area from Tg:Pax7CT2::Cripto(A) mice and the
Tg:Cripto(A) control littermates was calculated in TA muscles and reported in
the chart. Values are mean ± SEM, 5 mice/group. *P ≤ 0.05.
of Pax7+/MyoD+ cells; ∗P ≤ 0.05; Figures 4F,G); thus
providing in vivo evidence that adult satellite cell specific Cripto
overexpression accelerated myogenic lineage progression.
Taken together our results provide the first
in vivo evidence that Cripto overexpression in
myogenic compartment accelerates the early stages of
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regeneration process promoting satellite cell myogenic
commitment.
Discussion
Growing evidence link adult tissue repair to reactivation of
developmental gene program; nevertheless, our knowledge on
the role of key regulators of early vertebrate embryogenesis in
tissue regeneration is still limited also by the lack of adequate
in vivo genetic tools. Indeed, transcription levels and timing
of expression of key developmental genes are finely tuned,
and experimental strategies to generate constitutive gain-of-
function and loss-of-function mouse mutants often result in
embryonic lethality. In this scenario, we have focused our
attention on the developmental gene Cripto, which is a key
regulator of vertebrate embryogenesis. Here we report the
generation and functional characterization of a conditional
Cripto gain-of-function mouse model Tg:DsRedloxP/loxPCripto-
eGFP as a complementary strategy to investigate the effects
of Cripto in postnatal and adult life, and potentially in all
cell types. Specifically, by crossing Tg:DsRedloxP/loxPCripto-eGFP
mice with a Tg:Pax7CreERT2 mouse line, we have investigated
the effect of satellite cell- Cripto overexpression on skeletal
muscle regeneration and overcome the limitation of the viral-
mediated approach (Guardiola et al., 2012). Consistent with our
previous data on isolated myofibers in culture, we provide in vivo
evidence that satellite cell overexpression of membrane Cripto
promotes myogenic commitment and differentiation. However,
unlike the viral-mediated overexpression of soluble Cripto
(sCripto; Guardiola et al., 2012), the positive effect of satellite cell
Cripto overexpression on skeletal muscle regeneration is time-
dependent, being restricted to the early phases of regeneration.
It is unlikely that the discrepancy in the two approaches is
due to protein configuration, i.e., membrane vs. soluble Cripto;
indeed, sCripto is able to rescue muscle regeneration defects
caused by the genetic ablation of Cripto in the satellite cells,
indicating that it can recapitulate the role of the endogenous
protein (Guardiola et al., 2012). Yet, it is important to consider
that Cripto is expressed both in myogenic and inflammatory cells
during regeneration. Thus, the different timing of regeneration
in the two models might be explained by the fact that while
the genetic overexpression is restricted to the satellite cells, the
viral-mediated sCripto overexpression has a broader effect and
likely affects both the myogenic and the inflammatory cells.
Further studies will be necessary to test this hypothesis by deeply
investigating the specific contribution of Cripto in inflammatory
cells, as well as the autocrine and/or paracrine effects of the
endogenous protein.
The positive effect of Cripto overexpression on skeletal muscle
regeneration indicated by the increased CSA at day 15 is the
expected consequence of its earliest effect on the satellite cell
compartment. First, the number of centrally located nuclei
is higher in Cripto overexpressing myofibers at day 8 after
injury; thus suggesting accelerated differentiation. Accordingly,
the myoblast fusion index is increased in postnatal MPCs isolated
from Cripto overexpressing mice. Finally, an in depth analysis
of Pax7±/MyoD± cell distribution shows that the number
of Pax7−/MyoD+ cells committed to differentiation increases
both in vivo and in vitro upon Cripto overexpression. We
thus conclude that not only the addition of sCripto protein
but also its overexpression in a more physiological context,
promotes/accelerates satellite cells commitment to differentiation
both in vitro and in vivo. Taken together our data provide
evidence that a timely overexpression of Cripto in the satellite
cells promotes myogenic commitment and fusion/differentiation
and transiently accelerates regeneration after acute injury. It
will be interesting to investigate in future studies the effect of
sustained Cripto overexpression on satellite cell self renewal and
regeneration after repeated muscle injury.
Finally, in line with the idea that early regeneration is
enhanced upon Cripto overexpression, we found that the
expression of Myostatin, a member of the TGFβ superfamily
which inhibits myoblasts differentiation and acts as a negative
regulator of skeletal muscle growth (Amthor et al., 2002;
Langley et al., 2002) is downregulated in Cripto overexpressing
mice. Interestingly, this Cripto/Myostatin inverse correlation is
consistent with previous findings on isolated myofibers in culture
showing that sCripto antagonizes Myostatin leading to increased
number of myoblast population committed to differentiation
(Pax7−/MyoD+) (Guardiola et al., 2012).
In conclusion, all together these findings broaden our
knowledge on the role of Cripto in skeletal muscle regeneration,
and add novel insights into its activity in the satellite cell
compartment. We believe that these novel mouse models, which
also offer the unique opportunity to study the effect of Cripto
in the regulation of satellite cell quiescence, activation and self-
renewal in vivo, will be instrumental to get fundamental insights
into the role of Cripto in skeletal muscle homeostasis and
regeneration, as an important step toward the therapeutic use of
this molecule.
Materials and Methods
Mice and Genotyping
To generate the pDsRedloxP/loxPCripto targeting vector, a mouse
Cripto cDNA (750 bp) (Minchiotti et al., 2001) -IRES-eGFP
cassette was cloned downstream of the Discosoma sp. red
fluorescent protein (DsRed) gene into the pGapDsRedloxP/loxP
vector, containing the CMV enhancer/chicken beta-actin
promoter (CMV/β-Actin) and two loxP sites flanking the
DsRed gene upstream of triple STOP-polyA sequences (kindly
provided by Dr. Silvia Brunelli). Briefly, a Xho-AflII 2.2 kb
DNA fragment spanning the Cripto-IRES-eGFP cassette
was excised from the pCripto-IRES-eGFP plasmid (kindly
provided by Dr. Giovanna L. Liguori), blunt ended and
cloned into the backbone of the pGapDsRedloxP/loxP vector
previously linearized with EcoR1 and filled in with Klenow
Fragment of DNA polymerase I (New England Biolabs). Proper
orientation of the inserted Cripto-IRES-eGFP DNA fragment
was verified by restriction digestion and DNA sequencing.
To generate the transgenic mice, a SalI DNA fragment
spanning the entire CMV/β-Actin/DsRedloxP/loxPCriptoIRES-
eGFP transcription unit released from the pDsRedloxP/loxPCripto
targeting vector was gel purified and injected into fertilized
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oocytes of FVB/N mice, in collaboration with the Core Facility of
Conditional Mutagenesis at San Raffaele Hospital, Milan, Italy.
The resulting mice were genotyped by PCR-based screening
using primers (a-a′) spanning the Cripto gene exon4-exon5
junction for the amplification of both Cripto wt (247 bp) and
transgenic (156 bp) alleles. The integrity of the transgene was
further evaluated by PCR using primers (b-b′) annealing on the
DsRed and eGFP sequences (2700 bp). Three out of sixty mice
analyzed (5%) were positive for the transgene and only one of
them (mouse 1) gave germline transmission of the transgene.
Two copies of the transgene, which segregate independently,
were identified in the genome of the founder mouse by Southern
blot analysis. After germline transmission, heterozygous
Tg:DsRedloxP/loxPCripto-eGFP(A) and Tg:DsRedloxP/loxPCripto-
eGFP(B) mice colonies were maintained by crossing with
wild-type FVB mice and named Tg:Cripto(A) and Tg:Cripto(B),
respectively.
For Southern Blot analysis, 20 ug of genomic DNA
was prepared from tail biopsies, digested with EcoRI and
blotted on Immobilion-Ny+ (Millipore). The 32P-labeled probe
was a PCR amplified DNA fragment spanning the eGFP
insert (546 bp) from the pDsRedloxP/loxPCripto vector. The
heterozygous Tg:Pax7CreERT2::DsRedloxP/loxPCripto-eGFP(A)/(B)
mice were generated by crossing Tg:Pax7CreERT2 (Mourikis
et al., 2012) with Tg:Cripto(A)/(B) animals; the offsprings of
these crosses were genotyped by double PCR analysis to identify
the Tg:Cripto (213 bp) and the Tg:Pax7CreERT2 (600 bp) alleles
(DsRedCripto for/rev and Pax7Cre for/rev primers). The DNA
was prepared from tail biopsy samples of breeding animals.
To induce genetic recombination, Tg:Pax7CreERT2::Cripto and
Tg:Cripto adult mice (5 weeks old) were injected intraperitoneally
(i.p.) with tamoxifen (60µg/g of body weight per day, Sigma–
Aldrich) once a day for 5 days. The genetic recombination
was verified by PCR analysis (primers c-c′) to distinguish the
transgenic (1995 bp) from the recombining (838 bp) allele. The
DNA was obtained from tibialis anterior (TA) muscle biopsy
samples. The primer sequences for PCR screening, genotyping
and genetic recombination analysis are reported in Table S1.
Cell Culture and Transfection
HEK-293T cells were grown in Dulbecco Modified Eagle
Medium (DMEM, Gibco) supplemented with 10% Fetal Bovine
Serum (FBS, Euroclone) and 1% penicillin-streptomycin
(EuroClone), and plated on six-well plates at a density of
2 × 105 cells/cm2. Twenty-four hours after plating, cells
were transfected with 4µg of DNA (pDsRedloxP/loxPCripto
± pCMV-Cre recombinase expression vector), using
Lypofectamin Transfecion Reagent (Life Technologies) following
manufacturer’s instructions. Forty-eight hours after transfection,
cells were fixed for immunofluorescence analysis or visualized
by fluorescence microscopy (DMI600; Leica), and images were
acquired on an Orca R2 camera (Hamamatsu).
Muscle Injections, Preparation, and Analysis
Tibialis Anterior (TA) muscles of adult Tg:Cripto(A)/(B)
transgenic mice were injected with either Cre recombinase-
encoding Adeno Associated Virus (AAV-Cre) or the empty
vector (AAV-Cntl) at 1 × 1012 genome copies/ml in 10µl.
Muscles were collected after 10 days and total protein extracts
were prepared for further analysis. The AAV vectors were
prepared by the AAV Vector Unit at ICGEB Trieste (http://
icgeb.org/avu-core-facility.html) by packaging AAV2 vector
genome backbone into AAV capsid serotype 9, as previously
described (Arsic et al., 2003). To induce muscle damage, 10µl of
cardiotoxin (CTX, 70µM in PBS, Sigma-Aldrich) were injected
in the TA muscles of adult (5 weeks old) Tg:Pax7CreERT2::Cripto
and Tg:Cripto mice. For morphometric analysis, muscles were
harvested at the indicated time points after damage, and frozen
in isopentane-cooled liquid nitrogen for cryosection. Myofiber
Cross Sectional Area (CSA) was analyzed on haematoxylin/eosin
(H&E) stained muscle sections using ImageJ software (freely
available software developed at the National Institutes of Health,
Bethesda, Maryland, USA). The number of myofibers having
more than one nucleus on total area was evaluated, as previously
described (Mittal et al., 2010).
All experiments were conducted in strict accordance with
the institutional guidelines for animal research and approved by
the Department of Public Health, Animal Health, Nutrition and
Food Safety of the Italian Ministry of Health in accordance with
the law on animal experimentation.
Western Blot
Western blot analysis was performed as previously described
(Parisi et al., 2003) on total protein extracts prepared from either
cells or TAmuscles samples. TA muscles were homogenized with
TissueLyserII (Qiagen) following manufacturer’s instructions.
These primary antibodies were used: Cripto (1:500, R&D
System), eMyHC (1:100, Developmental Studies Hybridoma
Bank), Gapdh (1:40.000, Abcam) and β-Actin (1:5000,
Sigma-Aldrich).
Isolation of Mouse Satellite Cells and in Vitro
Differentiation
Tg:Pax7CreERT2::Cripto and Tg:Cripto new-born mice were
injected i.p. with tamoxifen (10µM, 5µl) every day, from day 1
to day 5 after birth (P1–P5). Preparation ofMPCs from new-born
mice (P7) was performed as previously described (Rando and
Blau, 1994). Briefly the hindlimb and forelimb were removed and
separated from the bones. Muscles were mechanically minced
with surgical scissors and dissociated by enzymatic digestion
[600 U/ml Collagenase Type IV (Gibco) and 1.8 U/ml Dispase
II (Roche) in DMEM (Gibco)] at 37◦C for 2 h in the shaker.
Digestedmuscles were spinned at 500 rpm for 5′ and satellite cells
were spinned down from supernatant (1500 rpm for 10′). Cells
were plated on gelatin-coated dishes in proliferation medium
[1% Pen/Strep (EuroClone), 1% Glutamin (Euroclone), 20% FBS
(Euroclone), 2% UltraSerum (LifeScience) in DMEM (Gibco),]
and myoblast population was enriched by several pre-plating
steps (Richler and Yaffe, 1970). For Pax7/MyoD cell counting,
MPCs were cytospinned at a density of 50.000 cells/spot after 24 h
in proliferatingmedium. Formyogenic differentiation, myoblasts
were plated in 48 wells at a density of 2 × 104 cells/cm2 in
proliferation medium. After twenty-four hours, proliferation
medium was replaced with differentiation medium for 24–72 h
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[DMEM (Gibco) containing 2% (v/v) horse serum (Gibco) and
1% pen/strep (EuroClone)] and the fusion index was determined
as the ratio of the number of nuclei in myotubes (MF20+ cells
with n ≥ 2 nuclei) on the total nuclei (MF20+ cells).
Immunofluorescence Analysis
Cells were fixed for 10′ with 4% (wt/vol) paraformaldehyde
(PFA) in Phosphate Buffer Saline (PBS) and blocked with 1%
bovin serum albumin (BSA) in PBS. Primary antibodies used
were: Cripto (Parisi et al., 2003), MF20 (1:50, Developmental
Studies Hybridoma Bank), Pax7 (1:10, Developmental Studies
Hybridoma Bank) and MyoD (1:50, SantaCruz). Appropriate
fluorophore-conjugated secondary antibodies, Alexa Fluor 594
or 488 (1:600, Molecular Probes), biotin-conjugated goat anti-
mouse (Jackson), and Cy3- (Jackson) or 488- (Molecular Probes)
conjugated streptavidin were used for the visualization using
DMI600 or DM600 (Leica) fluorescence microscopes.
Muscles were freshly frozen and cut in cryostat sections.
Slides were fixed in 4% (wt/vol) PFA and processed as previously
described (Nicolas et al., 2005). Briefly, muscle sections were
permeabilized in ice-cold methanol for 6′ at −20◦C, and boiled
15min in 10mM sodium citrate pH 6. Unbinding sites were
blocked with 4% IgG-free BSA (Jackson) in PBS for 2–3 h at
RT followed by a second blocking step with AffiniPure Fab
Fragment goat anti-mouse IgG (Jackson). Primary antibodies
were as follows: eMyHC (1:50, F1.652-s, Developmental
Studies Hybridoma Bank), Pax7 (1:10, Developmental Studies
Hybridoma Bank) and MyoD (1:50, SantaCruz) Appropriate
fluorophore-conjugated secondary antibodies, Alexa Fluor 488
or 594 (1:600, Molecular Probes), biotin-conjugated goat anti-
mouse (Jackson) and Cy3- (Jackson) or 488- (Molecular Probes)
conjugated streptavidin were used for visualization. Nuclei were
counterstained with DAPI (1:100 in PBS, VinciBiochem) and
FluoSave Reagent (Calbiochem) was used for mounting. Labeling
was visualized by epifluorescent illumination using a DM600
microscope (Leica), and images were acquired on a DFC360-FX
camera (Leica).
ELISA-based Assay
ELISA–based assay was performed as previously described
(Guardiola et al., 2012). Briefly ninety-six well plates were
coated with 0.5µg/ml of sheep anti-mouse Cripto Ab (R&D
System, AF1538) in PBS overnight (O.N.) at 4◦C. Unbinding
sites were blocked with PBS-BSA 1% for 2 h at RT. After
washing, protein extracts (300µg) were added and plates were
incubated O.N. at 4◦C. The plates were incubated with 1µg/ml
of mouse Cripto biotinylated Ab (R&D System, BAF 1538) in
PBET (0.1% BSA, 5mM EDTA, 0.004% Tween-20 in PBS 1X pH
7,5) for 1 h at 37◦C, and then for 1 h at RT. Finally, the plates
were incubated for 1 h at RT with avidin/streptavidin complex
conjugated with horse-radish peroxidase (Vectastain elite ABC
kit, Vector Laboratories). The signals were visualized with o-
phenylenediamineperoxidase substrate (OPD, Sigma-Aldrich)
and the relative absorbance was read at 490 nm on a Benchmark
microplate reader (Bio-Rad Laboratories).
RNA Preparation and qRT-PCR
TA muscles were homogenized with TissueLyserII (Qiagen)
in TriReagent (Life Technologies) and total RNA was isolated
according to the manufacturer’s instructions. One microgram of
total RNA was utilized for cDNA synthesis using SuperScript II
Reverse Transcriptase and random hexamers (Qiagen). qRT-PCR
was performed using SYBR Green PCR master mix (EuroClone).
Primers are listed in Table S2.
Statistical Analysis
All values are expressed as mean ± Standard Error of the
Mean (SEM). To determine significance between two groups,
comparisons were made using unpaired Student t-tests. ∗P ≤
0.05, ∗∗P ≤ 0.005, and ∗∗∗P ≤ 0.0005 were considered
statistically significant.
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